Skip to content

Akreos AOP IOL ADAPTAOP0700Recalls & reported problems

Bausch & Lomb Incorporated · ADAPT-AOP 11.0MM +07.00 · Class 3 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10757770485731), received between Jul 20, 2023 and Jul 20, 2023 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Endophthalmitis1
  • Eye Pain1
  • Visual Impairment1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryJul 20, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT IS REPORTED THAT, ONE WEEK AFTER IMPLANTATION OF AN IOL, A PATIENT WAS FOUND TO HAVE VISUAL ACUITY LOSS, EYE PAIN, CONJUNCTIVAL CONGESTION, AND EDEMA, WHICH WAS LATER DIAGNOSED AS ENDOPHTHALMITIS. AFTER HOSPITALIZATION, THE SYMPTOMS IMPROVED, THE VISION RECOVERED, AND THE PATIENT WAS DISCHARGED. 10 DAYS POST-DISCHARGE A RE-EXAMINATION OF THE PATIENT SHOWED A RECURRENCE OF ENDOPHTHALMITIS. THE PATIENT WAS REFERRED TO ANOTHER HOSPITAL FOR FURTHER DIAGNOSIS AND TREATMENT.

    Patient problems: Endophthalmitis; Eye Pain; Visual Impairment

    MAUDE report 17365172 ↗

Other Intraocular Lens devices

All Intraocular Lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page